• Citer

Tumor metabolism assessed by FDG-PET/CT and tumor proliferation assessed by genomic grade index to predict response to neoadjuvant chemotherapy in triple negative breast cancer

par Groheux, D.;Biard, Lucie;Lehmann-Che, J.;Teixeira, L.;Bouhidel, Fatiha Amira;Poirot, Brigitte;Bertheau, P.;Merlet, Pascal;Espie, Marc;Resche-Rigon, Matthieu;Sotiriou, Christos ;de Cremoux, Patricia
Référence European journal of nuclear medicine and molecular imaging, 45, 8, page (1279-1288)
Publication Publié, 2018-07

Article révisé par les pairs

• Détails
• Contenu

Titre:	Tumor metabolism assessed by FDG-PET/CT and tumor proliferation assessed by genomic grade index to predict response to neoadjuvant chemotherapy in triple negative breast cancer
Auteur:	Groheux, D.; Biard, Lucie; Lehmann-Che, J.; Teixeira, L.; Bouhidel, Fatiha Amira; Poirot, Brigitte; Bertheau, P.; Merlet, Pascal; Espie, Marc; Resche-Rigon, Matthieu; Sotiriou, Christos; de Cremoux, Patricia
Informations sur la publication:	European journal of nuclear medicine and molecular imaging, 45, 8, page (1279-1288)
Statut de publication:	Publié, 2018-07
Sujet CREF:	Imagerie médicale, radiologie, tomographie
Mots-clés:	Event free survival
	FDG-PET/CT
	Genomic grade index
	Neoadjuvant chemotherapy
	Pathological complete response
	Triple negative breast cancer
MeSH keywords:	Cell Proliferation
	Fluorodeoxyglucose F18
	Genomics
	Humans
	Neoadjuvant Therapy
	Positron Emission Tomography Computed Tomography
	Positron-Emission Tomography
	Radiopharmaceuticals
	Retrospective Studies
	Tomography, X-Ray Computed
	Treatment Outcome
	Triple Negative Breast Neoplasms -- diagnostic imaging -- drug therapy -- genetics
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:1619-7070
	info:doi/10.1007/s00259-018-3998-z
	info:pii/10.1007/s00259-018-3998-z
	info:scp/85044747442
	info:pmid/29616304